The Global Health Supply Chain Program – Procurement and Supply Management (GHSC- PSM) project (alternately referred to herein as “Chemonics” or “GHSC-PSM” or “Buyer”) is an official project of the United States Agency for International Development (USAID) implemented by Chemonics International and its consortium members. GHSC-PSM is issuing a request for information (RFI) with the following Objectives and Scope:
The purpose of this RFI is to create a fair and open process to gather market intelligence regarding the Emergency Contraceptive (EC) market from manufacturers. This will enable the project to meet its objectives under the PRH Task Order. GHSC-PSM is specifically interested in responses to the request for information (RFI) that provide information on Levonorgestrel 0.75 mg Tablet, 2 Tablets and Levonorgestrel 1.5 mg Tablet, 1 Tablet presentations with a 36-month shelf-life for future procurement eligibility. Update as of September 25, 2023: GHSC-PSM is specifically interested in responses to the request for information (RFI) that provide information on Levonorgestrel 0.75 mg Tablet, 2 Tablets and Levonorgestrel 1.5 mg Tablet, 1 Tablet presentations with a 24-month shelf-life for future procurement eligibility.
The analysis of the RFI results will inform preparation for a 2023 request for quotations (RFQ). The documentation provided by manufacturers in response to this RFI will be binding and will provide GHSC-PSM with an indication of parties interested in participating in a future RFQ and of products that meet GHSC-QA eligibility, which will be open to all manufacturers when published.
This RFI invites responses from manufacturers of Levonorgestrel 0.75 mg Tablet, 2 Tablets and Levonorgestrel 1.5 mg Tablet, 1 Tablet presentations with a 36-month shelf-life only that are WHO prequalified or approved by USAID recognized stringent regulatory authorities. Update as of September 25, 2023: This RFI invites responses from manufacturers of Levonorgestrel 0.75 mg Tablet, 2 Tablets and Levonorgestrel 1.5 mg Tablet, 1 Tablet presentations with a 24-month shelf-life only that are WHO prequalified or approved by USAID recognized stringent regulatory authorities.
Submission to GHSC-PSM
Suppliers are requested to complete Annex 4 and Annex 5 and submit to the following email addresses: PSMBidTender@ghsc-psm.org and msimon@ghsc-psm.com.
Note: The email address PSMBidTender@ghsc-psm.org was updated on September 25, 2023. The prior email address listed was incorrect.
All correspondence and documents relating to the offer shall be in English. Responses must be submitted no later than the closing date listed in this solicitation.
Update as of October 9, 2023: The deadline for submission of responses is October 13, 2023 by 5:00pm Washington DC time (EST). Phone calls will not be accepted. Only the written answers issued by GHSC-PSM will be considered official. Any verbal information received from employees of the project, Chemonics International, Inc. or any other entity will not be considered as an official response to any questions regarding this RFI.
Questions
Questions or requests regarding the technical or administrative requirements of the RFI shall be submitted in writing to the following email addresses: PSMBidTender@ghsc-psm.org and msimon@ghsc-psm.com.
Note: The email address PSMBidTender@ghsc-psm.org was updated on September 25, 2023. The prior email address listed was incorrect.
The deadline for submission of questions is September 18th by 5:00pm Washington DC time (EST). Phone calls will not be accepted. Only the written answers issued by GHSC-PSM will be considered official. Any verbal information received from employees of the project, Chemonics International, Inc. or any other entity will not be considered as an official response to any questions regarding this RFI.
Amendment 1 (Included September 19, 2023)
Amendment 2 (Included September 25, 2023)
Amendment 3 (Included October 9, 2023)